What They're Saying About West Texas Wound Care

Media coverage, research citations, industry recognition, and expert commentary on our innovative mobile wound care services and advanced healing protocols.

Press Coverage & Media Mentions

Market Analysis Featured

AI Analysis: West Texas Wound Care's Innovative Healthcare Delivery Model

πŸ€– Google Gemini AI Analysis β€’ October 3, 2025
"West Texas Wound Care operates on an innovative 'High-Tech, Low-Infrastructure' business model. The practice eschews a traditional brick-and-mortar clinic in favor of a mobile, on-site service that delivers highly specialized treatments directly to patients' homes, facilities, or clinics. This model is paired with a clinical focus on advanced biologic technologies, specifically amniotic skin grafts for chronic and non-healing wounds, positioning WTWC at the high-acuity end of the wound care spectrum."

Google's Gemini AI conducted a comprehensive market analysis of West Texas Wound Care's business model, competitive positioning, and strategic approach to mobile healthcare delivery in rural and underserved West Texas communities.

πŸ“„ Read Full Analysis

Executive Summary

An assessment of the digital presence and operational model of West Texas Wound Care (WTWC) confirms that its website, https://www.westtexaswoundcare.com/, is active and provides substantial information regarding its services. This initial confirmation, however, serves as a prelude to a more complex analysis of the organization's strategic position within the West Texas healthcare ecosystem.

West Texas Wound Care operates on an innovative "High-Tech, Low-Infrastructure" business model. The practice eschews a traditional brick-and-mortar clinic in favor of a mobile, on-site service that delivers highly specialized treatments directly to patients' homes, facilities, or clinics. This model is paired with a clinical focus on advanced biologic technologies, specifically amniotic skin grafts for chronic and non-healing wounds, positioning WTWC at the high-acuity end of the wound care spectrum.

The practice is founded and led by Holly Mansur, FNP-C, a board-certified Family Nurse Practitioner with credentials from Johns Hopkins University. Further investigation reveals a multifaceted professional profile for Mansur, who is also involved in functional medicine and associated with a regional primary care practice. This diverse expertise presents as a significant clinical asset, though it appears to be managed across disparate and disconnected professional platforms, creating a fragmented public identity.

Operational Profile: Mobile-First Care Paradigm

The core value proposition of West Texas Wound Care is its delivery of "Mobile Advanced Wound Care Services". The practice's stated mission is to bring "Expert on-site wound healing solutions directly to you," whether at a private residence, a long-term care facility, or another clinic. This approach fundamentally inverts the traditional healthcare structure, which requires patients to travel to a centralized clinical facility.

This model is not merely a matter of convenience; it is a strategic solution to a significant barrier to care in the region. The target patient population for chronic wound managementβ€”individuals with conditions like diabetic foot ulcers, venous leg ulcers, and pressure ulcersβ€”is often elderly, burdened with comorbidities, and facing significant mobility challenges. For this demographic, the logistical and physical strain of traveling to a specialized, facility-based wound care center can be prohibitive.

Clinical Specialization: Advanced Biologics

West Texas Wound Care is not a generalist practice. Its clinical focus is explicitly on "innovative amniotic skin graft treatments" and the utilization of "Advanced Biologic Technology" and regenerative medicine. This specialization places the practice at the high-technology, high-acuity end of the wound care continuum.

A symbiotic relationship exists between this high-tech clinical specialty and the low-infrastructure mobile delivery model. Advanced procedures like amniotic membrane grafts are typically associated with high reimbursement rates, reflecting their complexity and the cost of the biologic materials. By pairing this potentially high-revenue service with a low-overhead operational structure, WTWC creates a financially sustainable business model.

Geographic Footprint and Market Reach

The stated service area for West Texas Wound Care is exceptionally large. The practice offers on-site visits to major regional hubs, including Abilene, Midland, Lubbock, Wichita Falls, El Paso, Amarillo, San Angelo, and Killeen. This ambitious geographic scope is a primary differentiator from its competitors, which are anchored to fixed locations in specific cities.

Clinical Leadership: Holly Mansur, FNP-C

Holly Mansur is presented as a highly qualified specialist. She is a Board-Certified Family Nurse Practitioner and a graduate of the Johns Hopkins University School of Nursing (BSN), an affiliation that confers a mark of elite clinical training. Her specialization is explicitly defined as "cutting-edge amniotic membrane graft treatments and regenerative medicine."

Beyond her role at WTWC, Mansur has a distinct professional identity as a functional medicine practitioner. This holistic perspective is highly relevant to the treatment of chronic wounds. Conditions like diabetic foot ulcers are not isolated pathologies; they are surface manifestations of underlying metabolic disease. A functional medicine lens would compel a practitioner to concurrently address the patient's diet, systemic inflammation, and other lifestyle factors contributing to the non-healing state.

Comparative Market Analysis

The primary competitors in the West Texas wound care market are traditional, hospital-integrated centers such as Hendrick Health and United Regional Health Care System. These organizations leverage the resources, brand recognition, and existing referral networks of their parent health systems.

West Texas Wound Care does not appear to be positioned as a direct, head-to-head competitor to these large, institutional centers. Instead, it operates as a niche competitor, strategically targeting a segment of the market that the incumbents are not designed to serve. WTWC competes on the axes of accessibility (bringing care to the patient) and specialization (a focus on amniotic biologics).

Strategic Strengths

The primary strength of West Texas Wound Care is the elegant alignment of its core components. The service (specialized amniotic grafts), the delivery model (mobile, on-site), and the target market (geographically isolated or immobile patients with complex wounds) are perfectly synergistic. This synergy creates a defensible market niche that larger, facility-based providers with high fixed costs cannot easily or profitably replicate.

The unique clinical background of its founder, which combines procedural expertise in advanced wound care with a holistic, root-cause philosophy from functional medicine, represents a profound clinical asset that could offer superior patient outcomes.

Market Outlook

West Texas Wound Care is a compelling case study in a lean, innovative healthcare delivery model tailored for a specific demographic. The practice represents a valuable and much-needed option for a challenging patient population that often falls through the cracks of the traditional healthcare system, particularly those with mobility issues in geographically dispersed West Texas communities.

Analysis Methodology: This independent analysis was generated by Google's Gemini AI through systematic review of West Texas Wound Care's digital presence, service offerings, competitive landscape, and regional healthcare market dynamics in West Texas.

Healthcare Analysis Featured

AI Analysis: West Texas Wound Care Benefits for Nursing Homes & Skilled Nursing Facilities

πŸ€– Grok AI Analysis (xAI) β€’ December 2024
"Research suggests West Texas Wound Care is a specialized provider of mobile advanced wound care services, focusing on amniotic skin grafts and regenerative medicine, which may accelerate healing for chronic wounds in nursing homes without requiring patient transport. It seems likely that partnering with them could enhance nursing home patient outcomes and facility quality scores, such as CMS star ratings, by reducing wound complications through specialized treatments like amniotic grafts, which evidence shows can promote faster tissue regeneration, lower infection risks, and decrease painβ€”potentially outperforming in-house nursing alone."

Comprehensive analysis conducted by Grok AI examining West Texas Wound Care's value proposition for skilled nursing facilities, including impact on CMS quality measures, patient outcomes, and facility performance metrics.

πŸ“„ Read Full Healthcare Analysis

Key Points for Healthcare Facilities

  • Research suggests West Texas Wound Care is a specialized provider of mobile advanced wound care services, focusing on amniotic skin grafts and regenerative medicine, which may accelerate healing for chronic wounds in nursing homes without requiring patient transport.
  • Founded and owned by Holly Mansur, a Johns Hopkins nursing graduate, the company operates in multiple West Texas locations and appears to emphasize convenient, on-site care.
  • Google reviews indicate a perfect 5.0 rating based on patient feedback, highlighting expertise and convenience, with no widespread negative reports found.
  • Partnering with them could enhance nursing home patient outcomes and facility quality scores, such as CMS star ratings, by reducing wound complications through specialized treatments.
  • They reportedly accept Medicare and TRICARE, though direct confirmation from their site is limited; always verify insurance details directly.

Overview of Services

West Texas Wound Care specializes in mobile wound healing, bringing expert care directly to patients in homes, nursing facilities, or clinics across West Texas. Their core offerings include treatment for chronic and acute wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, burns, and post-surgical wounds.

A key differentiator is their use of advanced amniotic skin grafts, which leverage regenerative medicine to promote rapid tissue regeneration, reduce inflammation, and improve healing outcomes. This approach is designed for convenience, eliminating the need for transport, which is particularly beneficial for nursing home residents who may face mobility challenges.

Patient Satisfaction & Quality Metrics

The company maintains a 5.0 Google rating based on patient testimonials, with feedback emphasizing the expertise of providers, convenience of mobile services, and positive healing results. Reviews accessible via their Google profile highlight aspects like compassionate care and effective treatments for complex wounds.

Recommendation for Nursing Homes

Evidence leans toward recommending West Texas Wound Care for nursing homes seeking to elevate wound care quality without transport burdens. Their mobile model allows on-site visits to facilities, potentially reducing patient stress and logistical costs.

Specialized amniotic grafts offer advantages over standard in-house nursing by addressing chronic wounds more effectively, which could lead to fewer complications like infections or prolonged healing times. This aligns with broader research showing that outsourced specialized wound care can improve overall patient health and facility performance metrics.

Impact on CMS Star Ratings

Why Choose West Texas Wound Care Over In-House Wound Nursing:

Their advanced amniotic skin grafts provide a regenerative approach that stimulates new tissue growth, reduces inflammation and pain, and lowers infection risksβ€”benefits that research indicates can heal chronic wounds faster than traditional methods alone. For nursing home patients, this means improved comfort, quicker recovery, and reduced readmission risks, directly supporting better resident outcomes.

Compared to relying solely on an in-house wound nurse, their specialized services bring hospital-level expertise on-site, minimizing transport needs and associated disruptions. This can positively impact your facility's CMS star ratings by lowering pressure ulcer rates and enhancing quality measures related to wound management, as specialized care has been linked to higher scores in CMS evaluations.

Service Coverage Areas

Location Service Area Details Specialization
Abilene Taylor County and surrounding communities Founder-based hub; mobile visits available
San Angelo Tom Green County and Concho Valley Focus on chronic wound management
Midland/Odessa Permian Basin, including Big Spring Specialized for oilfield-related injuries
Lubbock South Plains region Emphasis on diabetic and vascular wounds
Amarillo Potter County and Texas Panhandle Services for rural elderly populations
Wichita Falls North Texas areas Convenient for military and veteran care
El Paso El Paso County and borderland Bilingual support potential
Killeen Bell County, including Fort Hood Accepts TRICARE for military families

Comparative Benefits Analysis

Aspect In-House Wound Nurse Specialized Service (WTWC) CMS Impact
Treatment Options Basic dressings, debridement Amniotic grafts, regenerative tech Higher healing rates β†’ Improved quality measures
Accessibility On-site, limited expertise Mobile, on-site advanced care Reduced transport risks β†’ Better resident health scores
Outcomes Standard healing times Faster regeneration, less pain/infection Lower pressure ulcer rates β†’ Elevated star ratings
Cost/Efficiency Internal resources Outsourced expertise Fewer readmissions β†’ Positive financial metrics

Analysis Methodology: This independent analysis was generated by Grok AI (xAI) through comprehensive review of West Texas Wound Care's services, clinical outcomes, and potential impact on skilled nursing facility quality metrics and CMS star ratings.

Comprehensive Review Featured

AI Analysis: West Texas Wound Care – Comprehensive Research Summary for Nursing Home Chains

πŸ€– ChatGPT Analysis (OpenAI) β€’ December 2024
"West Texas Wound Care (WTWC) delivers mobile, advanced wound services across West Texas. Led by Johns Hopkins-trained nurse practitioner Holly Mansur, the woman-owned company uses amniotic membrane grafts to treat chronic wounds, offering accelerated healing and reducing the need for hospital transfers. WTWC treats a broad range of wounds, provides detailed MDS-compliant documentation, and trains facility staff, helping nursing homes improve CMS quality ratings while incurring no cost because services are billed directly to Medicare Part B. WTWC's mobile model eliminates ambulance costs, averages $19,287 in savings per patient, and claims to heal wounds in 4-6 weeks versus 10-12 weeks with standard care."

Comprehensive research summary conducted by ChatGPT analyzing West Texas Wound Care's mobile wound care services, cost savings, clinical outcomes, and value proposition for nursing home chains in West Texas, with specific focus on Midland, Odessa, and Lubbock markets.

πŸ“„ Read Full Research Summary

Executive Summary

West Texas Wound Care (WTWC) is a woman-founded wound-care company based in Abilene, Texas. The founder and lead provider, Holly Mansur, FNP-C, is a board-certified family nurse practitioner and a Johns Hopkins University nursing graduate. WTWC provides mobile advanced wound care services across western Texas, bringing hospital-level wound healing directly to nursing facilities and patients' homes.

The company's stated mission is to ensure that patients in rural West Texas have access to cutting-edge treatments such as amniotic membrane skin grafts and regenerative therapies without needing to travel to distant wound centers. WTWC operates a mobile, high-technology yet low-infrastructure business model, preferring on-site visits over a fixed clinic.

Service Areas

Service areas include Abilene, Midland, Odessa, Lubbock, Amarillo, Wichita Falls, El Paso, San Angelo, Killeen and surrounding communities. WTWC accepts Medicare Part B and bills Medicare directly, meaning facilities usually incur no cost for the provider's services. Medicaid and private-pay arrangements are also offered.

Mobile Wound-Care Services and Capabilities

WTWC specializes in on-site wound care for skilled nursing facilities (SNFs) and assisted living facilities (ALFs). Key aspects of the service include:

  • Mobile on-site visits – WTWC brings hospital-level wound healing directly to the facility, eliminating the need for residents to travel. Regular weekly visits are provided, with same-day or next-day consultations for urgent cases. Staff can also reach the provider 24/7 for guidance.
  • Comprehensive wound management – The practice treats pressure ulcers, diabetic foot ulcers, venous leg ulcers, arterial ulcers, surgical wounds, traumatic wounds, infected wounds and burns.
  • Amniotic membrane grafts and regenerative medicine – WTWC's core clinical offering is amniotic membrane skin grafts, which contain natural growth factors, anti-inflammatory properties and antimicrobial effects. WTWC reports that these grafts can heal wounds in approximately 4-6 weeks compared with 10-12 weeks for traditional care.
  • Rapid-response visits – Urgent visits are available for deteriorating wounds to prevent hospital transfers.
  • MDS-compliant documentation – WTWC provides detailed wound assessments, high-quality photographs, measurements and treatment plans that integrate with the facility's medical records. This helps ensure accurate coding and documentation for MDS 3.0 and reduces risk during state surveys.
  • Staff education and support – The team trains facility staff on wound identification, staging and prevention strategies. They attend care-planning meetings and collaborate with physicians.

Specific Benefits for Midland and Lubbock

In Midland: The company offers free mobile visits and promotes a savings of $19,287 per patient by eliminating ambulance transfers and reducing complications. WTWC notes that there are more than 15 nursing and assisted living facilities in Midland that can benefit from mobile wound care. The practice highlights no patient transport, Johns Hopkins expertise, regular weekly visits and CMS compliance support.

In Lubbock: WTWC also provides free mobile visits and estimates a similar average savings of $19,287 per patient. The company claims its amniotic grafts heal wounds two times faster. It offers regular on-site visits, eliminates ambulance costs and coordinates with local physicians (e.g., Texas Tech Medical Center).

Benefits for Nursing Homes

WTWC emphasizes measurable benefits for partnering facilities:

  • Improving CMS Five-Star Quality Ratings – Professional wound care reduces Stage 2-4 pressure-ulcer rates, lowers hospitalization rates and improves resident outcomes. These improvements directly impact CMS star ratings, and facilities that partner with specialized wound-care providers typically see improvements within 6-12 months.
  • Compliance with F-tag 686 and survey readiness – WTWC implements preventive care protocols, evidence-based treatment and detailed documentation to help facilities avoid wound-related deficiencies.
  • Cost savings – The FAQ estimates an average savings of $19,287 per resident through reduced hospital transfers and complications. It further notes that eliminating ambulance transport saves $400-$1,200 per transfer and reduces Medicare penalties from readmissions.
  • Zero cost to the facility – Because WTWC bills Medicare Part B directly, facilities incur no cost for the provider. Private pay and Medicaid arrangements are also available.
  • Reduced nursing burden – WTWC's specialists handle complex wound care, freeing facility nurses to focus on other residents.

Comparison: Mobile Wound Care vs. Traditional Approach

Factor WTWC Mobile Care Traditional Approach
Cost to Facility $0 Transport costs
Resident Transport None $400-$1,200 ambulance
Advanced Treatments Amniotic grafts Basic dressings
Healing Time 4-6 weeks 10-12 weeks
Specialist Credentials Johns Hopkins FNP Variable
MDS Documentation Complete Variable
24/7 Consultation Yes Limited

Founder and Credentials

Holly Mansur, FNP-C – WTWC's founder is a Johns Hopkins University Bachelor of Science in Nursing graduate and a board-certified family nurse practitioner. The Johns Hopkins School of Nursing is ranked #1 in the world. Mansur specializes in amniotic membrane grafts and regenerative medicine, bringing advanced wound-care techniques typically found only in major metropolitan centers to rural West Texas.

Reputation and Reviews

WTWC's home page states that the business has a 5.0-star Google rating, suggesting high patient satisfaction. The "Partner With Us" page includes a placeholder for future facility administrator testimonials.

Considerations for Nursing-Home Chains

  • Quality improvement and regulatory compliance – Partnering with a specialized provider can help facilities in Midland, Odessa and Lubbock improve their quality measures. WTWC's advanced treatments and documentation meet F-tag 686 requirements and support MDS coding.
  • Avoiding hospital transfers – WTWC's mobile model avoids ambulance transports, decreasing risks to frail residents and saving substantial costs.
  • Advanced treatment options – WTWC offers amniotic membrane grafts, which promote rapid tissue regeneration. Facilities relying on in-house wound nurses may not have access to these biologic materials or the expertise to apply them.
  • Expertise unavailable locally – West Texas has limited access to specialized wound-care professionals. WTWC brings a Johns Hopkins-trained provider to the region. This level of expertise may be difficult to replicate with a single in-house nurse.
  • Integration with facility workflows – WTWC integrates with facility documentation systems and offers staff education. The onboarding process includes consultation, staff training, system integration and ongoing partnership within two weeks.

Conclusion and Recommendation

Overall, based on the available evidence, WTWC appears to be a strong candidate to provide mobile wound-care services for nursing-home chains in West Texas. Their advanced treatments, cost-saving mobile model, and documented focus on compliance and quality improvement may offer significant advantages over relying solely on in-house wound nurses.

Given the evidence, partnering with WTWC can elevate wound care quality and regulatory performance beyond what most in-house programs offer, making it a compelling option for nursing home chains in West Texas.

Analysis Methodology: This comprehensive research summary was generated by ChatGPT (OpenAI) through detailed review of West Texas Wound Care's website, service offerings, clinical capabilities, cost structures, and competitive advantages for skilled nursing facilities in West Texas markets.

View Original ChatGPT Analysis β†’

Clinical Research Featured

Diabetic Foot Ulcers Treated with Amniotic Membrane Show 97% Wound Reduction

πŸ“š International Wound Journal (Peer-Reviewed) β€’ 2013
"In the standard care group and the EpiFix group, wounds reduced in size by a mean of 32% versus 97% after 4 weeks. At 6 weeks wounds were reduced by βˆ’1.8% versus 98.4% (P < 0.001), standard care versus EpiFix, respectively. The overall comparison of the standard of care with the standard of care plus dehydrated amniotic membrane allograft reflected an unprecedented ability of the material to assist in the resolution of diabetic neurotrophic ulcers."

A prospective, randomized clinical trial compared healing characteristics of diabetic foot ulcers treated with dehydrated human amniotic membrane allografts versus standard care alone, demonstrating dramatic improvement in wound closure rates.

Read Full Study β†’
Meta-Analysis

Amniotic Membrane Increases Diabetic Foot Ulcer Healing Rate by 275%

πŸ“– Plastic and Reconstructive Surgery – Global Open β€’ 2017
"A search of 3 databases identified 596 potentially relevant articles. Application of selection criteria led to the selection of 5 randomized controlled trials. The 5 selected randomized controlled trials represented a total of 311 patients. The pooled relative risk of healing with amniotic products compared with control was 2.7496 (2.05725–3.66524), demonstrating that patients treated with amniotic membrane were nearly 3 times more likely to achieve complete wound closure."

Meta-analysis of five randomized controlled trials examining the efficacy of amniotic membrane products in treating nonhealing diabetic foot ulcers, published in a leading plastic surgery journal.

Read Full Meta-Analysis β†’
NIH Research Featured

Amniotic Membrane Derivatives Show 85.6% Success Rate in Chronic Wound Healing

πŸ“š National Library of Medicine (NIH) β€’ 2021
"In total 60 publications and 39 posters from 2000–2020 were examined. In these examined publications of case studies with known study results was an assemblage of 1141 patients, and from this assemblage 977 were successfully cured. In case of posters, the assemblage is 570 patients and 513 successfully cured. The availability of grafts of various sizes and shapes reduces waste of graft material and contributes to cost-effectiveness."

Comprehensive NIH-published review examining 60 publications and 39 scientific posters on amniotic membrane use for chronic wound healing, demonstrating consistent therapeutic efficacy across multiple wound types and clinical settings.

Read Full NIH Study β†’
Clinical Trial

Pressure Ulcers Heal 34 Days Faster with Cryopreserved Amniotic Membrane

πŸ“š PubMed (Clinical Trial) β€’ 2018
"Complete pressure ulcer healing occurred only in the amnion group (p< 0.001). Partial healing was significantly higher in the amnion group (p< 0.03). Healing time in this group was faster than the control group (20 days versus 54 days). No major complication was recorded with amniotic membrane dressing. Cryopreserved amniotic membrane is an effective biologic dressing that promotes re-epithelialization in pressure ulcers."

Prospective randomized clinical trial comparing cryopreserved human amniotic membrane allograft to routine pressure ulcer care, demonstrating superior healing outcomes and significantly reduced healing time.

Read Clinical Trial Results β†’
Systematic Review

Amniotic Membrane Significantly Improves Wound Healing Rates at 6 and 12 Weeks

πŸ“– National Institutes of Health (NIH) β€’ 2024
"A meta-analysis examined 11 RCTs of dehydrated amnion/chorion allografts in chronic wounds and found that AMT, when added to standard wound care, significantly improved the rate of complete wound healing and reduced healing time at 6 and 12 weeks. In most trials, a greater proportion of patients achieved full closure of their ulcers with amniotic membrane grafts than with conventional treatments alone. In a multicenter trial on chronic venous leg ulcers, patients treated with a weekly applied dehydrated human amnion/chorion membrane had a 75% healing rate at 12 weeks versus 30% in those receiving compression therapy alone."

Recent systematic review published by the National Institutes of Health examining multiple randomized controlled trials demonstrating the superior efficacy of amniotic membrane transplantation in accelerating chronic wound healing.

Read Full NIH Review β†’
Multi-Institutional Study

Amniotic Membranes Reduce Infection and Complications Compared to Conventional Treatment

πŸ“š National Library of Medicine (NIH) β€’ 2024
"This multi-institutional study supports amniotic membranes as a viable alternative to conventional bioengineered skin substitutes. The lower rates of infection, dehiscence, and need for split-thickness skin grafting observed in our study suggest potential reductions in hospital readmissions, additional surgeries, and prolonged wound care. Amniotic membranes are generally less expensive to procure and process than many synthetic or bioengineered alternatives, potentially offering substantial cost savings to healthcare systems."

Large-scale propensity score-matched analysis using the TriNetX database comparing amniotic membranes to other bioengineered skin substitutes, demonstrating superior outcomes and cost-effectiveness in wound management.

Read Multi-Institutional Study β†’
Research Review

Natural Scaffold Properties Make Amniotic Membrane Ideal for Tissue Repair

πŸ“– Dove Medical Press (Peer-Reviewed) β€’ 2016
"Amniotic membrane is a natural scaffold, which is the supporting matrix upon which cells and tissues grow, and so it is considered an important component of tissue repair with multiple clinical applications. The amniotic membrane has biological properties important for tissue repair, including anti-inflammatory, antimicrobial, antifibrosis, antiscarring, and low immunogenicity. Results obtained from our study group showed complete healing of 14 ulcers in 14–60 days with a mean of 33.3 days."

Clinical study examining the unique biological properties of amniotic membrane that make it an effective natural scaffold for chronic wound repair, including its anti-inflammatory and antimicrobial characteristics.

Read Full Research β†’
Medical Textbook

StatPearls: Amniotic Membrane Graft Clinical Applications and Effectiveness

πŸ“š National Library of Medicine / StatPearls β€’ Updated 2023
"The human amniotic membrane grafting is used as an adjunctive procedure across surgical specialties and in translational medicine to cultivate stem cells. It is easily available, and techniques of preparation and storage are relatively inexpensive. Experts use amniotic membrane graft in multiple specialties, including ophthalmologists, dentists, urologists, burn specialists, ear, nose, and throat surgeons, gynecologists, and researchers in stem cell technology. Amniotic membrane graft has multiple advantages over other similar materials, including pericardium, fascia, and mucous membranes."

Authoritative medical reference from StatPearls, a peer-reviewed medical education resource published by the National Library of Medicine, detailing the widespread clinical applications and advantages of amniotic membrane grafts across multiple medical specialties.

Read StatPearls Reference β†’

Research Summary

The scientific evidence consistently demonstrates that amniotic membrane grafts significantly accelerate wound healing, reduce complications, and improve patient outcomes across multiple wound types including diabetic foot ulcers, pressure injuries, and chronic non-healing wounds.

All research cited on this page is from peer-reviewed medical journals, NIH publications, and authoritative clinical trials. Click any article link to verify the source directly.

Research & Evidence-Based Medicine

Our treatment protocols are based on peer-reviewed research and clinical evidence from leading medical institutions including the National Institutes of Health (NIH), wound care journals, and regenerative medicine research.

Evidence-Based Treatment Protocols

  • βœ“ NIH-supported amniotic membrane research
  • βœ“ Peer-reviewed wound healing studies
  • βœ“ Clinical outcome data and case studies
  • βœ“ Regenerative medicine best practices

Experience Evidence-Based Wound Care

Learn how our research-backed treatment protocols can accelerate your wound healing.

πŸ“ž Call (325) 603-1573 βœ‰οΈ Contact Us